Boston Scientific

Open: 54.0 Close: 53.6 Change: -0.4

Is Boston Scientific Company Inc Stock a good investment? This what an AI found.

How much time have you spent trying to decide whether investing in Boston Scientific? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: …

Concept Map

Semantic Network

Stock Summary

Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat.

Today's Summary

Boston Scientific has signed a definitive agreement to acquire medical technology company Relievant Medsystems. The Intracept Intraosseous Nerve Ablation System for the treatment of a type of chronic low back pain. Needham remains a Buy on Boston Scientific.

Today's News

Boston Scientific expects to close the transaction in the first half of 2024. Boston Scientific has signed a definitive agreement to acquire medical technology company Relievant Medsystems. The Intracept Intraosseous Nerve Ablation System for the treatment of a type of chronic low back pain. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. Boston Scientific was formed forty-four years ago, on June 29, 1979. Boston Scientific has set a standard for implementing an integrative organizational culture. The company is 6 among the Top 20 Industry Supporters Boston Scientific is one of several manufacturers of a medical device called transvaginal mesh. Boston Scientific – #35 4.4 stars 2019 Best Places to Work. Boston Scientific - #56 4.3 stars Best Place to Work 2022. Boston Scientific agreed to acquire Relievant Medsystem Medsystem, a medical technology company that developed a chronic back pain system for low back pain, for an upfront payment of $850m upfront (1) by Lara Sanli and Lara Daley. Boston Scientific Corp. per Employee $297.78K P/E Ratio 90.10 E/E ratio 90.59 Yield N/A Dividend N/a Ex-Dividend Date. Average Volume 7.35M Performance 5 Day 1 Month 5.59% 3 Month -0.69% YTD 15.84% Boston Scientific Q1 sales rose 12% from a year ago to $3.39 bln, above the FactSet consensus. Needham remains a Buy on Boston Scientific. Vascular Clinical Specialist - Birmingham/Montgomery Work mode: Field Based Territory:  United States. Responsibilities unique to this position are having a good understanding of the lab/operating room. Boston Scientific is dedicated to creating healthier communities in a wealth of ways. The Boston Scientific Foundation is a non-profit that works to help other non-profits. Boston Scientific Foundation Europe was established five years ago to help non-profits based on that continent. Boston Scientific employees help to determine which organizations receive grants. Boston Scientific is in the Health Care sector and Health Care Equipment & Supplies industry. Other companies in Boston Scientifics space include Steris, Masimo and Envista Holdings. Fast Five by MassDevice: Boston Scientific makes a $850M acquisition, InBrain Neuroelectronics wins FDA breakthrough nod - medical design sourcing. The S&P 500 and the Nasdaq dropped to a more than one-month low on Thursday. Mike Mahoney is the Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the Board) of CVS Health, effective November 1. With more than 45,000 global employees, Boston Scientific reaches over 33 million. Boston Scientific ( NYSE:BSX – Get Free Report ) last issued its quarterly earnings results on Thursday, July 27th. Boston Scientific has a 12-month low of $37.74 and a 12 month high of $55.38.

Stock Profile

"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts."

Keywords

This document will help you to evaluate Boston Scientific without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, medical, company, low, technology, back, and the most common words in the summary are: boston, scientific, stock, medical, news, market, bsx, . One of the sentences in the summary was: The Intracept Intraosseous Nerve Ablation System for the treatment of a type of chronic low back pain. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #boston #scientific #stock #medical #news #market #bsx.